Transcription of Reference ID: 3860969
{{id}} {{{paragraph}}}
Example: bachelor of science
Reference ID: 3860969
HIGHLIGHTS OF PRESCRIBING INFORMATION Marked bradycardia : Cases of marked bradycardia , some of which These highlights do not include all the information needed to use have resulted in cardiac arrest, have been observed within minutes BRIDION safely and effectively. See full prescribing information after administration. Monitor for hemodynamic changes and for BRIDION. administer anticholinergic agents such as atropine if clinically significant bradycardia is observed. ( ). BRIDION (sugammadex) Injection, for intravenous use Respiratory Function Monitoring: Ventilatory support is mandatory Initial Approval: 2015 for patients until adequate spontaneous respiration is restored and the ability to maintain a patent airway is assured.
5.2 Marked Bradycardia Cases of marked bradycardia, some of which have resulted in cardiac arrest, have been observed within minutes after the administration of BRIDION [see Adverse Reactions (6.2)]. Patients should be closely monitored for hemodynamic changes during and after reversal of neuromuscular blockade. Treatment
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: